Astellas Greece & Cyprus MD, Harry Nardis, emphasizes the importance of integrity, compliance and innovation to the Astellas business model, key priorities, navigating the Greek pharmaceutical landscape while maintaining a high-quality reputation, and retaining the company’s vision of being at the forefront of healthcare change.
Having assumed the leadership position for Astellas Hellas in the last year, what have been your key priorities?
"Astellas is committed to being at the forefront of healthcare change to turn innovative science into value for patients."
